Celebrating ten years of productive partisanship.

x - close

Advancing Regenerative Cellular Therapies for Americans

KEYWORDS: BILL FRIST

WHEN: Wednesday, December 2, 2015 5:00 a.m. to 6:30 a.m. ET

WHERE: Hart Senate Office Building (Room 216), Constitution Avenue NE & First Street NE, Washington, DC, 20002

Add to Calendar

Recent scientific advances in the field of regenerative cellular therapies have the potential to benefit many patient needs, including applications in cardiology, neurology, ophthalmology, orthopedics, and organ transplantation. However, significant regulatory challenges must be overcome if we are to fulfill the promise that cellular therapy holds for overcoming illness and injury.

The Bipartisan Policy Center released recommendations on ways the United States can accelerate the availability of safe and effective cellular therapies to Americans and improve U.S. competitiveness. Following remarks by former Senator Bill Frist, MD and former Representative Bart Gordon, a panel of scientific experts discussed groundbreaking research in the field.

Read the Report
Advancing Regenerative Cellular Therapy: Medical Innovation for Healthier Americans


Keynote remarks by:

Bill Frist, MD
Co-Chair, FDA: Advancing Medical Innovation, BPC
Former Senate Majority Leader
@bfrist

Bart Gordon
Co-Chair, FDA: Advancing Medical Innovation, BPC
Former U.S. Representative from Tennessee

Panel discussions with:

Anthony Atala, MD
Director of the Wake Forest Institute for Regenerative Medicine
W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University

Joanne Kurtzberg, MD
Professor of Pediatrics and Professor of Pathology, Duke University of Medicine
Chief Scientific Officer, Robertson Clinical and Translational Cell Therapy Program

C. Randal Mills, PhD
President and CEO, California Institute for Regenerative Medicine

Andre Terzic, MD, PhD
Director, Mayo Clinic Center for Regenerative Medicine

Andrew von Eschenbach, MD
President, Samaritan Health Initiatives
Former Commissioner, Food and Drug Administration

Moderated by:

Janet Marchibroda
Director of Health Innovation, BPC